Legend Biotech

Youtube Subscribe

Open: 64.0 Close: 69.7 Change: 5.7

The best way to get informed about Legend Biotech Company Inc Stock without reading hundreds of pages.

The game is changing. There is a new strategy to evaluate Legend Biotech fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Legend Biotech are: Legend, stock, Biotech, consensus, company, Analyst, past, …

Concept Map

Semantic Network

Stock Summary

Legend Biotech Corporation is a clinical-stage biopharmaceutical company. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM) The company also.

Today's Summary

Legend Biotech stock is up almost 9% in Friday afternoon trading. Analyst consensus calls Legend Biotechnology stock a Strong Buy based on 10 Buys assigned in the past three months. Leaked abstract on a phase 3 trial for the companys multiple myeloma drug Carvykti gave the stock a jolt.

Today's News

Legend Biotech stock is up almost 9% in Friday afternoon trading. Analyst consensus calls Legend Biotechnology stock a Strong Buy based on 10 Buys assigned in the past three months. The stock has risen 14.26% over the past month. Analyst Price Forecast Suggests 18.65% Upside. Average one-year price target for Legend Biotech Corp – ADR is $74.15. Projected annual revenue for Legend biopharmaceutical company is $206MM, an increase of 76.14%. Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. The stocks 50-day simple moving average is $48.41 and its 200-day moving average of $49.13. InvestorsObserver issues critical PriceWatch Alerts for LEGN, ABT, JNJ, KO, and TSLA. For Legend Biotech Corporation Sponsored ADR, the consensus EPS estimate for the quarter has been revised 12.9% higher over the last 30 days to the current level. Legend Biotech Corp reported earnings per share of -$0.42 and sales of $42.6M for the current quarter. Leaked abstract on a phase 3 trial for the companys multiple myeloma drug Carvykti gave the stock a jolt. The consensus among 13 polled investment analysts is to buy stock.

Stock Profile

"Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery, development, manufacturing, and commercialization of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia , gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It has collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of ciltacabtagene autoleucel. Legend Biotech Corporation was founded in 2014 and is based in Somerset, New Jersey. Legend Biotech Corporation is a subsidiary of Genscript Biotech Corporation."

Keywords

This document will help you to evaluate Legend Biotech without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Legend Biotech are: Legend, stock, Biotech, consensus, company, Analyst, past, and the most common words in the summary are: biotech, stock, legend, news, share, market, legn, . One of the sentences in the summary was: Legend Biotech stock is up almost 9% in Friday afternoon trading. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #biotech #stock #legend #news #share #market #legn.

Read more →

Youtube Subscribe

---